Human fibrinogen/Human thrombin (Mallinckrodt)

N/A

Report date: 2022/03/17 09:57:05

Base Information

Drug NameHuman fibrinogen/Human thrombin (Mallinckrodt)
Drug Alias NameFactor IIa/factor IHuman thrombin/Human fibrinogenHuman fibrinogen/Human thrombinFactor I/factor IIaThrombin/Fibrinogen +[7] 
ClassificationBiologics > Blood components
Mechanisms of ActionFibrinogen replacementsThrombin replacements
TargetsNot applicable
Therapy Area/IndicationsPostoperative HemorrhageBlood Loss, SurgicalHemorrhage
Global Approved IndicationsHemorrhage
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2015/03/19
Country/TerritoryBelgiumUnited StatesNetherlands +[5] 
CombinationsYes
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesMallinckrodt
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMallinckrodt Pharmaceuticals Ireland LtdMallinckrodt
Active IndicationsN/A
Inactive IndicationsPostoperative HemorrhageBlood Loss, SurgicalHemorrhage

Other Information

ATC CodeN/A
Related LinksN/A